1.0 2016-06-03 10:24:24 UTC 2026-08-22 05:35:08 UTC viomycin SmallMolecule Viomycin is an organic compound with the formula C25H43N13O10. Viomycin belongs to the hybrid peptides, a subclass of peptidomimetics within the organic compounds. With an average molecular weight of 685.69 g/mol, viomycin is a heavy molecule. It is found in healthcare, pharmaceuticals, and veterinary products as an antibiotic. Recorded exposure routes for this compound include oral and inhalation. In terms of biological activity, viomycin acts as an inhibitor of the 16S/23S rRNA (cytidine-2'-O)-methyltransferase TlyA (tlyA) protein target. C25H43N13O10 685.69 685.325584661 (3S)-3,6-diamino-N-[(3S,6Z,9S,12S,15S)-6-[(carbamoylamino)methylidene]-3-[(4R,6S)-6-hydroxy-2-imino-1,3-diazinan-4-yl]-9,12-bis(hydroxymethyl)-2,5,8,11,14-pentaoxo-1,4,7,10,13-pentaazacyclohexadecan-15-yl]hexanamide viomycine 32988-50-4 [H][C@@]1(C[C@H](O)NC(=N)N1)[C@]1([H])NC(=O)\C(NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H](CNC1=O)NC(=O)C[C@@H](N)CCCN)=C\NC(N)=O InChI=1S/C25H43N13O10/c26-3-1-2-10(27)4-16(41)32-12-6-30-23(47)18(11-5-17(42)37-24(28)36-11)38-20(44)13(7-31-25(29)48)33-21(45)14(8-39)35-22(46)15(9-40)34-19(12)43/h7,10-12,14-15,17-18,39-40,42H,1-6,8-9,26-27H2,(H,30,47)(H,32,41)(H,33,45)(H,34,43)(H,35,46)(H,38,44)(H3,28,36,37)(H3,29,31,48)/b13-7-/t10-,11+,12-,14-,15-,17-,18-/m0/s1 GXFAIFRPOKBQRV-GHXCTMGLSA-N Organic compounds Benzenoids Benzene and substituted derivatives Phenoxyacetic acid derivatives Phenoxyacetic acid derivatives Alkyl aryl ethers Azacyclic compounds Carbonyl compounds Carboxylic acids Dicarboximides Hydrocarbon derivatives Monocarboxylic acids and derivatives Organic oxides Organonitrogen compounds Phenol ethers Phenoxy compounds Thiazolidinediones Thiocarbamic acid derivatives Alkyl aryl ether Aromatic heteromonocyclic compound Azacycle Carbonyl group Carboxylic acid Carboxylic acid derivative Dicarboximide Ether Hydrocarbon derivative Monocarboxylic acid or derivatives Organic nitrogen compound Organic oxide Organic oxygen compound Organoheterocyclic compound Organonitrogen compound Organooxygen compound Phenol ether Phenoxy compound Phenoxyacetate Thiazolidine Thiazolidinedione Thiocarbamic acid derivative Aromatic heteromonocyclic compounds Detected and Not Quantified Viomycin Action Pathway SMP0126771 Viomycin Drug Metabolism Action Pathway SMP0144159 logp -11 logp -3.43 ALOGPS logs -2.82 ALOGPS solubility 1.04e+00 g/l ALOGPS logp -11 ChemAxon pka_strongest_acidic 10.5 ChemAxon pka_strongest_basic 10.14 ChemAxon iupac (3S)-3,6-diamino-N-[(3S,6Z,9S,12S,15S)-6-[(carbamoylamino)methylidene]-3-[(4R,6S)-6-hydroxy-2-imino-1,3-diazinan-4-yl]-9,12-bis(hydroxymethyl)-2,5,8,11,14-pentaoxo-1,4,7,10,13-pentaazacyclohexadecan-15-yl]hexanamide ChemAxon average_mass 685.69 ChemAxon mono_mass 685.325584661 ChemAxon smiles [H][C@@]1(C[C@H](O)NC(=N)N1)[C@]1([H])NC(=O)\C(NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H](CNC1=O)NC(=O)C[C@@H](N)CCCN)=C\NC(N)=O ChemAxon formula C25H43N13O10 ChemAxon inchi InChI=1S/C25H43N13O10/c26-3-1-2-10(27)4-16(41)32-12-6-30-23(47)18(11-5-17(42)37-24(28)36-11)38-20(44)13(7-31-25(29)48)33-21(45)14(8-39)35-22(46)15(9-40)34-19(12)43/h7,10-12,14-15,17-18,39-40,42H,1-6,8-9,26-27H2,(H,30,47)(H,32,41)(H,33,45)(H,34,43)(H,35,46)(H,38,44)(H3,28,36,37)(H3,29,31,48)/b13-7-/t10-,11+,12-,14-,15-,17-,18-/m0/s1 ChemAxon inchikey GXFAIFRPOKBQRV-GHXCTMGLSA-N ChemAxon polar_surface_area 390.36 ChemAxon refractivity 171.46 ChemAxon polarizability 66.95 ChemAxon rotatable_bond_count 10 ChemAxon acceptor_count 15 ChemAxon donor_count 16 ChemAxon physiological_charge 3 ChemAxon formal_charge 0 ChemAxon #<HealthEffect::ActiveRecord_Associations_CollectionProxy:0x00007f72676a74e0> DB06827 3037981 2301596 BE0009727